In the last trading session, 16.1 million Moderna Inc (NASDAQ:MRNA) shares changed hands as the company’s beta touched 1.82. With the company’s per share price at $26.39 changed hands at $1.53 or 6.15% during last session, the market valuation stood at $10.21B. MRNA’s last price was a discount, traded about -545.96% off its 52-week high of $170.47. The share price had its 52-week low at $23.15, which suggests the last value was 12.28% up since then.
Analysts gave the Moderna Inc (MRNA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.83. If we narrow down to specifics, the data shows that 2 out of 17 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended MRNA as a Hold, 12 felt it is a Buy and 0 rated the stock as Underweight.
Moderna Inc (NASDAQ:MRNA) trade information
Instantly MRNA was in green as seen at the end of in last trading. With action 2.68%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -36.53%, with the 5-day performance at 2.68% in the green. However, in the 30-day time frame, Moderna Inc (NASDAQ:MRNA) is 6.78% up.
The consensus price target for the stock as assigned by Wall Street analysts is 47.5, meaning bulls need an upside of 44.44% from its current market value. According to analyst projections, MRNA’s forecast low is 45 with 50 as the target high. To hit the forecast high, the stock’s price needs a -89.47% plunge from its current level, while the stock would need to soar -70.52% for it to hit the projected low.
Moderna Inc (MRNA) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -42.94%. The 2025 estimates are for Moderna Inc earnings to decrease by -9.43%, but the outlook for the next 5-year period is at 20.24% per year.
Moderna Inc (NASDAQ:MRNA)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 10.3028% or 39.56 million shares worth $4.7 billion as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund. With 10.87 shares estimated at $286.83 million under it, the former controlled 2.81% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard 500 Index Fund held about 2.37% of the shares, roughly 9.17 shares worth around $241.87 million.
